Jaffetilchin Investment Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,840
Closed -$49.5K 675
2024
Q3
$49.5K Buy
+1,840
New +$48.4K ﹤0.01% 588
2023
Q3
Sell
-10,587
Closed -$271K 347
2023
Q2
$271K Buy
+10,587
New +$251K 0.03% 300
2020
Q1
Sell
-56,222
Closed -$1.95M 179
2019
Q4
$1.95M Buy
56,222
+542
+1% +$18.3K 0.42% 48
2019
Q3
$1.8M Buy
55,680
+732
+1% +$25K 0.43% 42
2019
Q2
$1.88M Buy
+54,948
New +$1.85M 0.44% 39

Other funds holding FFTY

Jaffetilchin Investment Partners's FFTY Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of CapForce IBD 50 ETF (FFTY) in Q4 2024, closing a stake of 1,840 shares — an estimated $49.5K sold.

Jaffetilchin Investment Partners first reported a position in FFTY in Q2 2019 and held it in 5 quarters. The position peaked at $1.95M in Q4 2019. 32 funds tracked by Wall St. Rank hold FFTY as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining CapForce IBD 50 ETF position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 1,840 CapForce IBD 50 ETF shares in Q4 2024, an estimated $49.5K.
  • Jaffetilchin Investment Partners first reported a position in CapForce IBD 50 ETF in Q2 2019 and held it in 5 quarters.
  • Jaffetilchin Investment Partners's CapForce IBD 50 ETF position peaked at $1.95M in Q4 2019.
  • 32 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.